Skip to main content
Charlesbank Capital Partners

Charlesbank Capital Partners

Based in Boston and New York City, Charlesbank is a leading middle-market private investment firm with $21.5 billion in assets under management as of 3/31/2026. Drawing on nearly three decades of experience and sector insights, the firm takes a thematic approach to investing across its target sectors: business and consumer services, healthcare, industrials and technology & technology infrastructure. Charlesbank partners with talented management teams to help businesses unlock value and accelerate growth, with a focus on long-term value creation. The firm provides flexible capital through its complementary private equity and credit strategies, which collaborate closely to harness the firm’s collective capabilities, resources and network. Disclaimer: The information on this page is for informational purposes only. Nothing on or within this page constitutes a solicitation, offer, recommendation or representation of suitability or endorsement of any security or investment or any product of Charlesbank or Charlesbank-managed funds. Charlesbank is not responsible for any content posted by third parties to this page.www.charlesbank.com

Search complete. 3 mentions across 2 episodes found for "Charlesbank Capital Partners".

Oct 28, 2026

Seth DeutschGUEST
22:27
I can only speak to it generally within their MSO structure.
Seth DeutschGUEST
22:31
The second more important one, because it's visible, and now we're about to see three more deals come behind it And I facilitated with Aprio, Charles Bank's first investment into the legal industry, which most people have missed, which was when they, and we podcast about this with Andy, my friend Andy, who did our first, who helped me do my first MSO in the United States years ago, when he sold, when he merged his corporate law firm into Aprio Legal with Charles Bank as their sponsor.
Seth DeutschGUEST
23:06
Their move with Wood Smith, right, at a, let's just call it 16 to 18 times valuation, about 40 million of comp adjusted normalized EBITDA.
Seth DeutschGUEST
23:16
This, what people need to understand is that as a national firm with one of the best and brightest sponsors buying them that used to run the endowment for Harvard.

30 MINS LATER

Seth DeutschGUEST
53:33
where we've already proven- that the MSO holds and works in personal injury.
Seth DeutschGUEST
53:38
We're now proving that it works in ID, insurance defense.
Seth DeutschGUEST
53:43
And certain investors have, now that that has happened, now that Charles Bank's investment committee is doing this, gives other ICs a lot of confidence.
Seth DeutschGUEST
53:59
Then we see the Misumi deal and you're about to see the other one, which I can't say, but you'll be announced here soon.
Mathieu RocheHOST
12:40
By the
Bill WiseGUEST
12:41
way, in your intro, you missed a 2021 transaction to CVC, TA, and Charles Bank, now Eterna, for $2.1 billion.
Mathieu RocheHOST
12:51
Oh, just a little miss.
Mathieu RocheHOST
12:53
Okay, so it's not Vista anymore, it's CVC.

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click “Accept All” to consent, or “Decline non-essential” to opt out of non-essential cookies. Read our Privacy Policy.